Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells

This publication has 13 references indexed in Scilit:

• 10,11-Methylenedioxycamptothecin, a Topoisomerase I Inhibitor of Increased Potency: DNA Damage and Correlation to Cytotoxicity in Human Colon Carcinoma (HT-29) Cells
  Cancer Communications, 1990
• Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity ofcis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline
  Cancer Chemotherapy and Pharmacology, 1990
• Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cells
  European Journal of Cancer and Clinical Oncology, 1990
• Nonproductive Rearrangement of DNA Topoisomerase I and II Genes: Correlation With Resistance to Topoisomerase Inhibitors
  JNCI Journal of the National Cancer Institute, 1989
• Unknotting the Complexities of Multidrug Resistance: The Involvement of DNA Topoisomerases in Drug Action and Resistance
  JNCI Journal of the National Cancer Institute, 1989
• DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
  Annual Review of Biochemistry, 1989
• Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino) methane-sulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase ii in a murine mastocytoma cell line
  Biochemical Pharmacology, 1989
• Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.
  Journal of Clinical Investigation, 1987
• Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA
  Nature, 1987
• DNA TOPOISOMERASES
  Annual Review of Biochemistry, 1985